Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
Police have arrested four men in connection to the suspected terror-linked murder of a police worker in Sydney.
Volkswagen could start recalling cars containing emissions cheating software in January, according to the firm's new chief executive.
A toddler survived for days on his own after his mother collapsed and died as she fed his one-year-old brother - who also choked to death.